The finding of an increase in MDM2 expression by low-dose chronic radiation is consistent with previous studies in both murine cells and human cancer cells24, 25 Considering the dose-dependent increase in the expression of CDKN1A and MDM2, the activities of p53, which mainly depend on protein modifications, should also change dose-dependently. The gene discussed is TP53; the disease is cancer.